Primary lymphoma of the orbit. Case report
DOI:
https://doi.org/10.5281/zenodo.12520792Keywords:
exophthalmia, eye neoplasms, non-Hodgkin lymphoma, orbit; paresisAbstract
Introduction: orbital lymphoma is a very rare type of tumor that affects the orbit and ocular adnexa and is rarely bilateral. It is essential to make an early diagnosis and initiate timely treatment to avoid complications.
Objective: to present the case of a patient with non-Hodgkin lymphoma of the orbit.
Case presentation: 37-year-old patient with a history of arterial hypertension, ischemic stroke with right hemiparesis sequelae, and polycystic kidneys. Two months ago, while he was undergoing rehabilitation therapy, he reported an increase in volume of the left orbital region, which increased in size over the days, for which he was hospitalized and diagnosed as orbital non-Hodgkin lymphoma.
Conclusions: it constitutes the first case in the Teaching Clinical Surgical Hospital "Manuel Ascunce Domenech" of Camagüey in more than 60 years, despite registering an increase in the incidence in the last decades. Knowledge of this condition is necessary, where care by a multidisciplinary team is essential to establish the conduct to follow and to be successful in treatment.
Downloads
References
Kirkegaad M, Couplands S, Prause J, Heegard S. Malignant Lymphoma of the Conjuntiva. Surv Ophthamol [Internet]. 2015 [citado 20 Oct 2020];60(5):4444-58. https://pubmed.ncbi.nlm.nih.gov/26003619/
Galnares-Olalde J, Farrell-González L, Cadena-Machado J, Muñoz-Abrahan O. Linfoma Orbitario: Reporte de un caso y revisión de la literatura. Rev Mex Oftalmol [Internet]. 2014 [citado 20 Oct 2020];88(3):141-145. Disponible en: https://www.elsevier.es/es-revista-revista-mexicana-oftalmologia-321-pdf-S018745191400050X
Munch-Peterson H, Rasmussen P, Coupland S, Esmaeli B, Finger P, Grave G, et al. Ocular Adnexal Diffuse Large B-cell lymphoma: A Multicenter International Study. JAMA Ophthalmol [Internet]. 2015 [citado 20 Oct 2020];13(3):82-9. Disponible en: https://jamanetwork.com/journals/ophth/articlepdf/1935406/eoi140101.pdf
Gadegaard-Hindso T, Esmaeli B, Holm F, Hjorth-Mikkelsen L, Kristian-Rasmussen P, Coupland SE, et al. International multicentre retrospective cohort Study of ocular adnexal marginal zone B-cell lymphoma. Br J Ophthalmol [Internet]. 2019 [citado 20 Oct 2020];104(3):357-362. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31177189/
Seresirikachorn K, Norasetthada L, Ausayakhun S, Apivatthakakul A, Tangchittam S, Pruksakorn V, et al. Clinical presentation and treatment outcomes of primary ocular adnexal MALT lymphoma in Thailand. Blood Res [Internet]. 2018 [citado 20 Oct 2020];53(4):307-13. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300677/pdf/br-53-307.pdf
Cabrera-Pérez C, Santana-Álvarez J, Rodríguez-Bencomo D, Olivera-Moran O, Miranda MA. Linfoma no Hodgkin con infiltración ocular: a propósito de un caso. AMC [Internet]. 2016 [citado 20 Oct 2020];20(2):212-8. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-02552016000200014
Abreu FA, Ortiz DL, Santos D, González JL, Fernández O, Caballero Y. Características clínicas y patológicas de los tumores orbitarios. Rev Cubana Oftalmol [Internet]. 2018 [citado 20 Oct 2020];31(2):[aprox. 12 p.]. Disponible en: http://scielo.sld.cu/pdf/oft/v31n2/a07_554.pdf
Gómez-Margolles Y, García-Sánchez D, Trujillo-Azcagua L. Supervivencia de los pacientes con linfoma no Hodgkin difuso B de células grandes. Acta Méd Cent [Internet]. 2017;11(3):[aprox. 12 p.]. Disponible en: https://web.archive.org/web/20180417124344id_/http://www.medigraphic.com/pdfs/medicadelcentro/mec-2017/mec173a.pdf
Di Nisio LA, Zárate J, Weil D. Linfomas orbitarios. Oftalmol Clin Exp [Internet]. 2017 [citado 20 Oct 2020];10(3):88-93. Disponible en: https://oftalmologos.org.ar/oce_anteriores/files/original/85d0df52554683f634a250a2e3b1e095.pdf#page=22
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Pedro Rosales Torres
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
